Area of research
Pathology and Forensic Medicine · Hematology
Research interest
Research interests include Lymphoma Diagnosis and Treatment, Acute Myeloid Leukemia Research, Chronic Lymphocytic Leukemia Research, and Acute Lymphoblastic Leukemia research.
Mapping VEXAS-associated and rare UBA1 variants in the United Kingdom: Insights from patient cohorts and the general population.
COVID-19-related mortality in a real-world cohort of 18 883 patients with premalignant and malignant haematological neoplasms: An analysis from the UK's Haematological Malignancy Research Network.
Estimating the Causal Effect of Realistic Treatment Strategies Using Longitudinal Observational Data.
Patient and Public Involvement and Engagement within a UK blood cancer cohort: a case study.
Adverse Health Events in Chronic Myeloid Leukaemia Patients Treated With Tyrosine Kinase Inhibitors 2009-2019: A Real-World Study From the UK's Haematological Malignancy Research Network.
Clinical outcomes of patients with lower risk myelodysplastic syndrome from EUMDS registry eligible for transplantation: Implications for transplantation strategies.
Global patterns of leukemia by subtype, age, and sex in 185 countries in 2022.
Somatic mutations and DNA methylation identify a subgroup of poor prognosis within lower-risk myelodysplastic syndromes.
Survival and quality of life in patients with lower risk myelodysplastic syndromes exposed to erythropoiesis-stimulating agents: an observational cohort study.
Infections in lower-risk myelodysplastic syndromes - prevalence and risk factors: a report from the European MDS Registry.
Doubling in median survival in patients diagnosed with multiple myeloma 2005-2019; a real-world study from the UK's Haematological Malignancy Research Network.
Predicting cytopenias, progression, and survival in patients with clonal cytopenia of undetermined significance: a prospective cohort study.
The influence of immunodeficiency, disease features, and patient characteristics on survival in plasmablastic lymphoma.
Lymphoid blood cancers, incidence and survival 2005-2023: A report from the UK's Haematological Malignancy Research Network.
Inflammatory profile of lower risk myelodysplastic syndromes.
Information preferences of patients with chronic blood cancer: A qualitative investigation.
Pathways of patients with chronic haematological malignancies: a report from the UK’s population-based HMRN
2024cited by 0position: contributor
Multiparameter prediction of myeloid neoplasia risk
Multiparameter prediction of myeloid neoplasia risk.
Cause of death and excess mortality in patients with lower-risk myelodysplastic syndromes (MDS): A report from the European MDS registry.
Determinants of low health-related quality of life in patients with myelodysplastic syndromes: EUMDS Registry study.
Experiences and preferences for psychosocial support: a qualitative study exploring the views of patients with chronic haematological cancers.
Raising the standards of patient-centered outcomes research in myelodysplastic syndromes: Clinical utility and validation of the subscales of the QUALMS from the MDS-RIGHT project.
Patient perspectives of 'Watch and Wait' for chronic haematological cancers: Findings from a qualitative study.
Chronic myeloid leukaemia: A qualitative interview study exploring disease impact from patient and practitioner perspectives.
Longitudinal expression profiling identifies a poor risk subset of patients with ABC-type diffuse large B-cell lymphoma.
Author Correction: Multiparameter prediction of myeloid neoplasia risk
An Economic Model to Establish the Costs Associated With Routes to Presentation for Patients With Multiple Myeloma in the United Kingdom.
Correction: Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes
Cohort profile: the United Kingdom Childhood Cancer Study (UKCCS) - a UK-wide population-based study examining the health of cancer survivors.